Cargando…

Coordinate PI3K pathway and Bcl-2 family disruption in AML

Detalles Bibliográficos
Autores principales:	Bose, Prithviraj, Rahmani, Mohamed, Grant, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681487/ https://www.ncbi.nlm.nih.gov/pubmed/23439314

Ejemplares similares

Rational Combinations of Targeted Agents in AML
por: Bose, Prithviraj, et al.
Publicado: (2015)

Targeting PI3Kδ and PI3Kγ signalling disrupts human AML survival and bone marrow stromal cell mediated protection
por: Pillinger, Genevra, et al.
Publicado: (2016)

Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML
por: Lindblad, O, et al.
Publicado: (2016)

Bcl-2 Is Involved in Cardiac Hypertrophy through PI3K-Akt Pathway
por: Meng, Xianwei, et al.
Publicado: (2021)

Managing chronic lymphocytic leukemia in 2020: an update on recent clinical advances with a focus on BTK and BCL-2 inhibitors
por: Bose, Prithviraj, et al.
Publicado: (2021)

Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells
por: Fiskus, Warren, et al.
Publicado: (2019)

p53 pathway dysfunction in AML: beyond TP53 mutations
por: Post, Sean M., et al.
Publicado: (2017)

The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells
por: Nepstad, Ina, et al.
Publicado: (2020)

Ruxolitinib for essential thrombocythemia?
por: Bose, Prithviraj, et al.
Publicado: (2017)

NHERF1: molecular brake on the PI3K pathway in breast cancer
por: Georgescu, Maria-Magdalena
Publicado: (2008)

Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence
por: Darici, Salihanur, et al.
Publicado: (2020)

Disrupting autophagy in FLT3-mutant acute myeloid leukemia
por: Grant, Steven
Publicado: (2022)

Anticancer Effects of Fufang Yiliu Yin Formula on Colorectal Cancer Through Modulation of the PI3K/Akt Pathway and BCL-2 Family Proteins
por: Dong, Bingzi, et al.
Publicado: (2020)

UCB HCT in FLT3+ AML
por: Ustun, Celalettin, et al.
Publicado: (2017)

Myocardial protection of propofol on apoptosis induced by anthracycline by PI3K/AKT/Bcl-2 pathway in rats
por: Zhang, Xiaobei, et al.
Publicado: (2022)

The RAS‐PI3K‐AKT‐NF‐κB pathway transcriptionally regulates the expression of BCL2 family and IAP family genes and inhibits apoptosis in fibrous epulis
por: Jiang, Yangyang, et al.
Publicado: (2019)

Modulation of the PI3K/Akt Pathway and Bcl-2 Family Proteins Involved in Chicken’s Tubular Apoptosis Induced by Nickel Chloride (NiCl(2))
por: Guo, Hongrui, et al.
Publicado: (2015)

PI3K/AKT/mTOR pathway in tumor progression of oligodendrogliomas
por: Lisi, Lucia
Publicado: (2020)

Oligo-Porphyran Ameliorates Neurobehavioral Deficits in Parkinsonian Mice by Regulating the PI3K/Akt/Bcl-2 Pathway
por: Liu, Yingjuan, et al.
Publicado: (2018)

RACKI induces chemotherapy resistance in esophageal carcinoma by upregulating the PI3K/AKT pathway and Bcl-2 expression
por: Liu, Bowen, et al.
Publicado: (2018)

BCL2 Inhibition: A New Paradigm for the Treatment of AML and Beyond
por: Wei, Andrew H., et al.
Publicado: (2023)

Targeting glutamine uptake in AML
por: Jacque, Nathalie, et al.
Publicado: (2014)

AML treatment in older adults
por: Sehgal, Alison, et al.
Publicado: (2015)

Impact of CNA on AML prognosis
por: Gonzales, Fanny, et al.
Publicado: (2017)

Regulation of Apoptosis by the Bcl-2 Family of Proteins: Field on a Brink
por: Ladokhin, Alexey S.
Publicado: (2020)

Hyper-activated PI3K-δ in immunodeficiency
por: Heurtier, Lucie, et al.
Publicado: (2015)

Is PI3K a Villain in Cystic Fibrosis?
por: Natarajan, Viswanathan
Publicado: (2020)

BCL11A Facilitates Cell Proliferation and Metastasis in Neuroblastoma via Regulating the PI3K/Akt Signaling Pathway
por: Jin, Qianya, et al.
Publicado: (2022)

Inhibiting CCN1 blocks AML cell growth by disrupting the MEK/ERK pathway
por: Niu, Chang-Chun, et al.
Publicado: (2014)

Maintenance of elderly AML patients with androgens
por: Pigneux, Arnaud, et al.
Publicado: (2017)

In quest for leukemia initiating cells in AML
por: De Grandis, Maria, et al.
Publicado: (2018)

Allosteric activation of PI3Kα by oncogenic mutations
por: Burke, John E., et al.
Publicado: (2013)

The role of PI3Kγ in metabolism and macrophage activation
por: Solinas, Giovanni, et al.
Publicado: (2017)

PI3K inhibition potentiates Bcl-2-dependent apoptosis in renal carcinoma cells
por: Zhu, Shudong, et al.
Publicado: (2013)

BCL6B suppresses proliferation and migration of colorectal carcinoma cells through inhibition of the PI3K/AKT signaling pathway
por: Gu, Yue, et al.
Publicado: (2018)

BCL2L10/BECN1 modulates hepatoma cells autophagy by regulating PI3K/AKT signaling pathway
por: He, Jiafa, et al.
Publicado: (2019)

COVID-19 disruption: Family physicians at the forefront
por: Hugo, Johannes F.
Publicado: (2021)

B7-H3 Induces Ovarian Cancer Drugs Resistance Through An PI3K/AKT/BCL-2 Signaling Pathway
por: Zhou, Li, et al.
Publicado: (2019)

PI3Kβ downstream of GPCRs – crucial partners in oncogenesis
por: Dbouk, Hashem A., et al.
Publicado: (2012)

Modulation of PI3K signaling to improve CAR T cell function
por: Zheng, Wenting, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tns510j7qr7tggk91mqqnp0qf9